Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Delfi Diagnostics
AddedFeb 13, 2024
UpdatedJun 18, 2026
Delfi Diagnostics

Delfi Diagnostics

Delfi Diagnostics: Developing accessible blood tests for early cancer detection and prevention.

HQ
Baltimore, MD, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Delfi Diagnostics, founded with a mission to revolutionize cancer detection and prevention, focuses on developing high-performing, accessible blood tests for early cancer detection. Leveraging novel machine learning algorithms, Delfi's technology analyzes fragments of cell-free DNA to identify cancer from a single blood sample. Their flagship clinical trial, CASCADE-LUNG, aims to enroll approximately 15,000 participants, underscoring their commitment to scalable and accurate cancer screening solutions.

Notable figures associated with Delfi Diagnostics include Dr. Velculescu, an internationally recognized expert in genomics and cancer research, known for pioneering genome-wide sequence analysis in human cancers. Delfi's team comprises leading experts in cancer biology, bioinformatics, machine learning, and public health. The company's innovative approach has the potential to significantly impact early cancer detection, offering a more comprehensive and accessible screening method compared to existing technologies.

Delfi Diagnostics - Similar Companies

Delphi Diagnostics logo

Delphi Diagnostics

Freenome logo

Freenome

freenome.com

Cleveland Diagnostics logo

Cleveland Diagnostics

clevelanddx.com

Helio Health logo

Helio Health

heliohealth.com

Guardant Health logo

Guardant Health

guardanthealth.com

Droplet Biosciences logo

Droplet Biosciences

dropletbiosci.com

Precipio logo

Precipio

precipiodx.com

Pharus Diagnostics logo

Pharus Diagnostics

pharusdx.com

Hawkeye Bio logo

Hawkeye Bio

hawkeyebio.com

Adela logo

Adela

adelabio.com

Thrive Earlier Detection logo

Thrive Earlier Detection

Cadex Genomics logo

Cadex Genomics

cadexgenomics.com

Harbinger Health logo

Harbinger Health

Circulogene Theranostics logo

Circulogene Theranostics

circulogene.com

Lucence logo

Lucence

lucence.com

Delfi Diagnostics - Quick Facts

Who are Delfi Diagnostics' competitors?

Companies similar to Delfi Diagnostics include Delphi Diagnostics, Freenome, Cleveland Diagnostics and Helio Health.

When was Delfi Diagnostics founded?

Delfi Diagnostics was founded in 2019.

Where is Delfi Diagnostics' headquarters located?

Delfi Diagnostics' headquarters is located in Baltimore, MD, US.

When was Delfi Diagnostics' last funding round?

Delfi Diagnostics' most recent funding round was for $225M (USD) in July 2022.

How much has Delfi Diagnostics raised to-date?

As of Jul 18, 2022, Delfi Diagnostics has raised a total of $330.5M (USD).

How many employees does Delfi Diagnostics have?

Delfi Diagnostics has 235 employees as of Feb 5, 2024.

Delfi Diagnostics - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Blood Tests
  • Cancer Detection
Tags
  • Biotech
  • Data
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified